Sex,PrEP, and Stigma: Experiences with HIV Pre-exposure Prophylaxis Among New York City MSM Participating in the HPTN 067/ADAPT Study |
| |
| Authors: | Julie Franks Yael Hirsch-Moverman Avelino S. LoquereJr. K. Rivet Amico Robert M. Grant Bonnie J. Dye Yan Rivera Robert Gamboa Sharon B. Mannheimer |
| |
| Affiliation: | 1.ICAP at Columbia University, Harlem Prevention Center,New York,USA;2.Department of Epidemiology,Columbia University Mailman School of Public Health,New York,USA;3.Department of Health Behavior and Health Education,University of Michigan,Ann Arbor,USA;4.Gladstone Institutes,University of California, San Francisco,San Francisco,USA;5.FHI 360,Durham,USA;6.Harlem Hospital Center,New York,USA |
| |
| Abstract: | ![]()
The HPTN 067/Alternative Dosing to Augment Pre-Exposure Prophylaxis Pill Taking (ADAPT) study evaluated daily and non-daily dosing schedules for oral pre-exposure prophylaxis (PrEP) to prevent HIV. A qualitative sub-study including focus groups and in-depth interviews was conducted among men who have sex with men participating in New York City to understand their experience with PrEP and study dosing schedules. The 37 sub-study participants were 68% black, 11% white, and 8% Asian; 27% were of Hispanic/Latino ethnicity. Mean age was 34 years. Themes resulting from qualitative analysis include: PrEP is a significant advance for HIV prevention; non-daily dosing of PrEP is congruent with HIV risk; and pervasive stigma connected to HIV and risk behavior is a barrier to PrEP adherence, especially for non-daily dosing schedules. The findings underscore how PrEP intersects with other HIV prevention practices and highlight the need to understand and address multidimensional stigma related to PrEP use. |
| |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ |
|
